After 42 years with the firm, Jim Medford has retired from the practice of law.
Jim previously served as Litigation Practice Area Leader due to his substantial experience in a number of varied areas of the law. He concentrated primarily on intellectual property litigation, white collar criminal defense and international business agreements with an emphasis on intellectual property and the CISG. His litigation practice emphasized patent infringement, unfair competition, trademark and trade secret litigation.
Jim's criminal law practice emphasized white collar criminal defense, especially Qui Tam cases and Medicare fraud and abuse counseling, investigations and trials. He tried numerous criminal cases to a jury verdict, including criminal antitrust bid-rigging cases as well as crimes of violence. He is a member of the White Collar Crime Committee of the ABA Section of Criminal Justice, and the National Association of Criminal Defense Lawyers.
He was actively involved defending hospitals in HHS and Justice Department national initiatives such as lab unbundling and pneumonia upcoding as well as regional matters such as MRI overreach.
As former head of the firm's International team, Jim also provided intellectual property counseling to a number of large corporations, domestic and foreign, including licensing, joint research and development, and joint venture work in the NAFTA region, Western Europe (with emphasis on Germany, Switzerland, and Denmark) as well as China and India. He counseled and represented foreign companies regarding the formation and further representation of their US subsidiaries. He also oversaw patent prosecution for these companies in the US and coordinated patent and trade secret litigation and opposition proceedings in Europe with similar matters in the United States. His clients included Evonik Corporation, Emery Oleochemicals GmbH; Ducon GmbH and Genan Inc.